Physiology and Antibiotic Susceptibility of Staphylococcus aureus Small Colony Variants
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Small colony variants (SCV) are slow-growing subpopulations with altered metabolism and reduced antibiotic susceptibility which, in the case of Staphylococcus aureus , can cause persisting and recurrent infections. We studied four SCVs and their corresponding parent strains: one clinical strain pair, one menaquinone-deficient spontaneous mutant, and two constructed mutants obtained by inactivation of hemB in S. aureus 8325-4 and COL, respectively. SCVs growing in chemically defined medium (CDM) with glucose limitation and enhanced buffering capacity were found to generate ΔΨ of -120 to -140 mV, which is comparable to the parent strains. However, glucose is consumed inefficiently with small growth yields. In contrast to wild-type strains, ΔΨ dropped immediately to values below -100 mV when glucose expired and other nutrients such as acetate and lactate did not allow for further growth. Accordingly, the sensitivity of SCVs toward antibiotics known to be taken up through ΔΨ, such as aminoglycosides, dropped 10- to 30-fold when compared to the parent strain under routine MIC determination conditions. When growing in CDM, the susceptibility of SCVs varied according to the magnitude of ΔΨ.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to aminoglycoside resistance, SCVs that arise via the loss of the electron transport chain are more tolerant than wild-type bacteria of other classes of bactericidal antibiotics (8, 9, 25–29).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [25]
Citations
Cites
Peschel, A., Otto, M., Jack, R. W., Kalbacher, H., Jung, G., & Götz, F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8405 · Cited by 994 · cited 1×
“15 However, acidification of TSB in the course of glucose consumption could also decrease the activity of aminoglycosides due to reduction of DC in favor of D pH. 5 Although the above experiments demonstrated the difference in susceptibility of wild-type strains and SCVs, information on whether the…”
Properties of a cryptic high-frequency transducing phage in Staphylococcus aureus
Novick, R. (1967) · Virology · doi:10.1016/0042-6822(67)90105-5 · Cited by 741
Growth characteristics of group A streptococci in a new chemically defined medium
van de Rijn, I., & Kessler, R. E. (1980) · Infection and Immunity · doi:10.1128/iai.27.2.444-448.1980 · Cited by 482
Persistent and Relapsing Infections Associated with Small-Colony Variants of Staphylococcus aureus
Proctor, R. A., van Langevelde, P., Kristjansson, M., Maslow, J. N., & Arbeit, R. D. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.1.95 · Cited by 437 · cited 4×
“…and altered utilization of carbohydrates, severely complicate the diagnostics of SCVs. Therapeutic complications arise from the frequent intracellular localization of SCVs 1,3,12,17,20,30 and from increased resistance to aminoglycosides, 17 cationic peptides, 7 and cell-wall active antibiotics.”
InfluentialSelf-citationRuhr, E., & Sahl, H. G. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.5.841 · Cited by 375 · cited 1×
“22 The membrane potential was calculated by means of the Nernst equation DC 5 ), where R is the gas constant, T the absolute temperature in Kelvin, F the Faraday’s constant, [TPP 1 in ] the molar concentration of TPP 1 inside the bacterial cells, and [TPP 1 out ] the molar concentration of TPP 1 in…”
Self-citationvon Eiff, C., Heilmann, C., Proctor, R. A., Woltz, C., Peters, G., & Götz, F. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.15.4706-4712.1997 · Cited by 310
Self-citationMolecular biology of the staphylococci
(1992) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(92)90178-m · Cited by 257
von Eiff, C., Bettin, D., Proctor, R. A., Rolauffs, B., Lindner, N., Winkelmann, W., & Peters, G. (1997) · Clinical Infectious Diseases · doi:10.1086/516962 · Cited by 247
Self-citationBalwit, J. M., Langevelde, P. V., Vann, J. M., & Proctor, R. A. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/170.4.1033 · Cited by 237 · cited 1×
“…and altered utilization of carbohydrates, severely complicate the diagnostics of SCVs. Therapeutic complications arise from the frequent intracellular localization of SCVs 1,3,12,17,20,30 and from increased resistance to aminoglycosides, 17 cationic peptides, 7 and cell-wall active antibiotics.”
Staphylococcal Small Colony Variants Have Novel Mechanisms for Antibiotic Resistance
Proctor, R. A., Kahl, B., von Eiff, C., Vaudaux, P. E., Lew, D. P., & Peters, G. (1998) · Clinical Infectious Diseases · doi:10.1086/514906 · Cited by 204
Self-citationBierbaum, G., & Sahl, H. G. (1987) · Journal of Bacteriology · doi:10.1128/jb.169.12.5452-5458.1987 · Cited by 191
Self-citationSahl, H. G., Kordel, M., & Benz, R. (1987) · Archives of Microbiology · doi:10.1007/bf00425076 · Cited by 191
Self-citationSmall Colony Variants in Staphylococcal Infections: Diagnostic and Therapeutic Implications
Proctor, R. A., & Peters, G. (1998) · Clinical Infectious Diseases · doi:10.1086/514706 · Cited by 160
Self-citationStaphylococcus aureus small colony variants, electron transport and persistent infections
McNamara, P. J., & Proctor, R. A. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(99)00170-3 · Cited by 148 · cited 2×
“…and altered utilization of carbohydrates, severely complicate the diagnostics of SCVs. Therapeutic complications arise from the frequent intracellular localization of SCVs 1,3,12,17,20,30 and from increased resistance to aminoglycosides, 17 cationic peptides, 7 and cell-wall active antibiotics.”
Self-citationMembrane potential and gentamicin uptake in Staphylococcus aureus.
Mates, S. M., Eisenberg, E. S., Mandel, L. J., Patel, L., Kaback, H. R., & Miller, M. H. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.21.6693 · Cited by 141 · cited 2×
“11 Because SCVs most frequently are defective in the electron transport chain, it is assumed that the reduced efficacy of aminoglycosides results from low DC .”
Variant subpopulations of Staphylococcus aureus as cause of persistent and recurrent infections.
Proctor, R. A., Balwit, J. M., & Vesga, Ó. (1994) · PubMed · Cited by 137
Self-citationKordel, M., Benz, R., & Sahl, H. G. (1988) · Journal of Bacteriology · doi:10.1128/jb.170.1.84-88.1988 · Cited by 126
Self-citationMorphology of defensin-treated Staphylococcus aureus
Shimoda, M., Ohki, K., Shimamoto, Y., & Kohashi, O. (1995) · Infection and Immunity · doi:10.1128/iai.63.8.2886-2891.1995 · Cited by 111 · cited 1×
“…to approximately 120 mM. Monovalent cations in such concentrations are known to interfere with binding of cationic antibiotics, e.g. , aminoglycosides and lantibiotics 4 or defensins, 7,26 to anionic cell wall polymers, which is known to be an important step for the activities of these compounds.”
Alteration of effectiveness of antibiotics by anaerobiosis.
Rm, V., & Gl, M. (1977) · PubMed · Cited by 108
Musher, D. M., Baughn, R. E., Templeton, G. B., & Minuth, J. N. (1977) · Journal of Infectious Diseases · doi:10.1093/infdis/136.3.360 · Cited by 87 · cited 1×
“2,12,13,20,21 SCVs are slow-growing subpopulations of S. aureus with characteristic phenotypic properties such as nonpigmented, non-hemolytic colonies on blood agar that may not become visible before 48 hr of incubation and may reach only 10% of the size of a regular S. aureus colony.”
Eisenberg, E. S., Mandel, L., Kaback, H. R., & Miller, M. H. (1984) · Journal of Bacteriology · doi:10.1128/jb.157.3.863-867.1984 · Cited by 84
Sahl, H. (1985) · Journal of Bacteriology · doi:10.1128/jb.162.2.833-836.1985 · Cited by 81 · cited 1×
“23 Aliquots were taken at later time points for Gram staining to evaluate the degree of autolysis.”
Self-citationKoo, S. P., Bayer, A. S., Sahl, H. G., Proctor, R. A., & Yeaman, M. R. (1996) · Infection and Immunity · doi:10.1128/iai.64.3.1070-1074.1996 · Cited by 80 · cited 2×
“…and altered utilization of carbohydrates, severely complicate the diagnostics of SCVs. Therapeutic complications arise from the frequent intracellular localization of SCVs 1,3,12,17,20,30 and from increased resistance to aminoglycosides, 17 cationic peptides, 7 and cell-wall active antibiotics.”
Self-citationHuman infections caused by thiamine- or menadione-requiring Staphylococcus aureus
Acar, J. F., Goldstein, F. W., & Lagrange, P. (1978) · Journal of Clinical Microbiology · doi:10.1128/jcm.8.2.142-147.1978 · Cited by 73 · cited 1×
“2,12,13,20,21 SCVs are slow-growing subpopulations of S. aureus with characteristic phenotypic properties such as nonpigmented, non-hemolytic colonies on blood agar that may not become visible before 48 hr of incubation and may reach only 10% of the size of a regular S. aureus colony.”
Abele-Horn, M., Schupfner, B., Emmerling, P., Waldner, H., & Göring, H. (2000) · Infection · doi:10.1007/s150100050014 · Cited by 65
Microcolonies (G-variants) of Staphylococcus aureus.
Quie, P. G. (1969) · PubMed Central · Cited by 43
Schnitzer, R. J., Camagni, L. J., & Buck, M. (1943) · Experimental Biology and Medicine · doi:10.3181/00379727-53-14192 · Cited by 42
Koo, S. P., Yeaman, M. R., & Bayer, A. S. (1996) · Infection and Immunity · doi:10.1128/iai.64.9.3758-3764.1996 · Cited by 41
von Eiff, C., Lindner, N. J., Proctor, R. A., Winkelmann, W., & Peters, G. M. (1998) · PubMed · Cited by 35
Self-citationMicrobial Pathogenic Factors: Small-Colony Variants
Proctor, R. A. (2014) · ASM Press eBooks · doi:10.1128/9781555818067.ch3 · Cited by 19 · cited 1×
“16,21 These features, along with reduced coagulase activity, 21 diminished a -toxin production, and altered utilization of carbohydrates, severely complicate the diagnostics of SCVs. Therapeutic complications arise from the frequent intracellular localization of SCVs 1,3,12,17,20,30 and from…”
Self-citationvon Eiff, C., Lindner, N., Proctor, R. A., Winkelmann, W., & Peters, G. (2008) · Zeitschrift für Orthopädie und ihre Grenzgebiete · doi:10.1055/s-2008-1054234 · Cited by 15
Self-citation
Cited by
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Lew, D. P., & Waldvogel, F. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16727-5 · Cited by 1,883
Proctor, R. A., von Eiff, C., Kahl, B. C., Becker, K., McNamara, P., Herrmann, M., & Peters, G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1384 · Cited by 1,175
“To study the reduction in aminoglycoside susceptibility, SCVs and their corresponding parent strains, including clinical isolates and defined mutants, were analysed for a decrease in membrane potential (ΔP), because ΔP is known to facilitate aminoglycoside uptak”
BackgroundSelf-citationHowden, B. P., Davies, J. K., Johnson, P. D. R., Stinear, T. P., & Grayson, M. L. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-09 · Cited by 962
“aureus have demonstrated reduced susceptibility to a number of antimicrobials including gentamicin, fluoroquinolones, and linezolid (16, 52, 264).”
BackgroundInsights into the mode of action of chitosan as an antibacterial compound.
Raafat, D., von Bargen, K., Haas, A., & Sahl, H.-G. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.00453-08 · Cited by 888
“aureus strains that are generally more resistant to the action of antimicrobials than their parent strain due to a decreased metabolism and a significantly reduced electrochemical gradient (2, 34).”
BackgroundSelf-citation
Metadata
- Authors
- Baumert, N., von Eiff, C., Schaaff, F., Peters, G., Proctor, R. A., & Sahl, H.-G.
- Affiliations
- University of Bonn (DE)
- Institut für Medizinische Mikrobiologie der Universität Münster, D-48149 Münster, Germany
- University of Münster (DE)
- University of Wisconsin–Madison (US)
- ORCID
- Proctor, Richard A.
- Venue
- Microbial Drug Resistance
- Publisher
- SAGE Publications
- Published
- 2002-12
- Volume
- 8
- Issue
- 4
- Pages
- 253-260
- ISSN
- 1076-6294 (ISSN-L)
- 1931-8448
- OpenAlex
- W2151124149
- Cited by
- 130
- References
- 32
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 4 · 2023: 4 · 2021: 3 · 2020: 5 · 2019: 5 · 2018: 3 · 2017: 7 · 2016: 9 · 2015: 9 · 2014: 6 · 2013: 7 · 2012: 5
- FWCI
- 3.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Microbial Drug Resistance (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (EI119912)
- National Institute of Allergy and Infectious Diseases (AI 42072, R01AI042072)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Keywords
- Staphylococcus aureus, small colony variants, antibiotic susceptibility, membrane potential, glucose limitation, aminoglycoside uptake, chemically defined medium, recurrent infections
- MeSH terms
- Acetates, Anti-Bacterial Agents, Culture Media, Glucose, Hydrogen-Ion Concentration, Kinetics, Membrane Potentials, Microbial Sensitivity Tests, Phenotype, Staphylococcal Infections, Staphylococcus aureus, Lactic Acid, Drug Resistance, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.